MAIA

MAIA Biotechnology Inc.

MAIA.US maiabiotech.com + Research + Basket
CIK 0001878313
Employees 13
Phone 312 416 8592
Fiscal year end December
IPO Jul 28, 2022
Address 444 West Lake Street, Chicago, IL, United States, 60606
1.18
+0.02 (+1.72%)
USD · AMEX
52-week range
0.87
3.19
Trading at 13% of the 52-week range
Market Cap
71.62M
P/E Ratio
0.00
Forward P/E
1.00
Book Value
0.34
Div. Yield
N/A
% Institutions
21.90%
% Insiders
14.41%

1 Year

-9.2%

3 Year

-41.0%

10 Year

-73.5%
Description

MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Actions

Add an action for MAIA.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Vlad Vitoc M.B.A., M.D. Co-Founder, President, CEO & Chairman of the Board of Directors 1970
Mr. Jeffrey C. Himmelreich M.B.A. Head of Finance and Principal Financial & Accounting Officer 1976
Dr. Sergei M. Gryaznov Ph.D. Chief Scientific Officer 1960
Linda Moreira Company Secretary NA

Financial Highlights

▼
Market Cap: $71.62M
Book Value: $0.34
Earnings/Share: $-0.62
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -92.10%
ROE (TTM): -218.68%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Valuation Metrics

Enterprise Value: $44.64M
Trailing P/E: 0.00
Forward P/E: 1.00

Shares Statistics

Shares Outstanding: 61.74M
Shares Float: 55.30M
% Insiders: 14.41%
% Institutions: 21.90%
Short % Float: 4.45%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$0.00
Gross Profit
subtotal
$0.00
SG&A
adjust
$-9.72B
R&D
adjust
$-14.55B
Operating Income
subtotal
$-24.27M
Other / Non-Operating Items
adjust
$1.87M
Net Income
subtotal
$-22.40M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about MAIA.US!